Robert W. Clarke;David L. Hava;Michal M. Lipp;Richard Batycky
发明人:
Robert W. Clarke,Richard Batycky,David L. Hava,Michal M. Lipp
申请号：
US13259666
公开号：
US20120083531A1
申请日:
2010.03.26
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to pharmaceutical compositions suitable for inhalation, comprising as an active ingredient calcium lactate or calcium citrate. The invention also relates to methods of treating, preventing, and reducing the spread of an infection of the respiratory tract, comprising administering a pharmaceutical composition that comprises calcium lactate or calcium citrate as an active ingredient.
